Concepedia

Esther van de Kerkhof

EV

Statistics

Publications

6

Citations

378

H-Index

6

Active since

1998

Affiliations

Novartis Institutes for BioMedical Research(Current)

Novartis (Switzerland)

Esther van de Kerkhof is an author at Novartis Institutes for BioMedical Research specializing in pharmacy, lymphoid tumors, and drug delivery.

Publications per year

1998–2014

6

Publications

6

bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.

Françoise A. M. J. Geelen, Maarten H. Vermeer, Chris J.L.M. Meijer et al. · Journal of Clinical Oncology · 1998 · 138 citations

, , +9

Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia.

Patrick W.B. Derksen, Anton W. Langerak, Esther van de Kerkhof et al. · PubMed · 1999 · 61 citations

, , +16

Biodistribution and Metabolism Studies of Lipid Nanoparticle–Formulated Internally [3H]-Labeled siRNA in Mice

Jesper Kammersgaard Christensen, Karine Litherland, Thomas Faller et al. · Drug Metabolism and Disposition · 2014 · 58 citations

, , +17

A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies

Ruben de Kanter, Annemarie Tuin, Esther van de Kerkhof et al. · Journal of Pharmacological and Toxicological Methods · 2004 · 56 citations

, , +9

Metabolism Studies of Unformulated Internally [3H]-Labeled Short Interfering RNAs in Mice

Jesper Kammersgaard Christensen, Karine Litherland, Thomas Faller et al. · Drug Metabolism and Disposition · 2013 · 49 citations

, , +15

1–5 of 6